Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"
Manager TitleAgeSince
Chief Operating Officer 64 2011-05-31
Chief Executive Officer 45 2024-12-31
Director of Finance/CFO - 2024-06-30
Director TitleAgeSince
Director/Board Member 45 2024-12-31
Chairman 63 2024-12-31
Director/Board Member - 2023-11-06
Date Insider Type Main position Quantity % Market Cap.
23-11-02Issuer sale

Founder

623,331 2.3043%
23-11-02Issuer sale

Director

88,556 0.3274%
23-11-02Issuer sale

Director

79,332 0.2933%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%+0.86% - - 284M
-1.00%-3.91%-45.27%-24.36% 24.9B
+1.06%+6.13%-35.87%+160.58% 12.66B
-0.72%-6.43%-17.65%+51.13% 5.57B
+2.44%+1.20% - - 2.9B
+4.47%+17.04% - - 1.86B
+1.43%+3.22%+39.32%-44.84% 1.78B
-1.76%-2.68%-21.92% - 1.31B
-0.29%-2.54%-31.62%-60.86% 792M
+1.39%-3.16%-36.23%+233.65% 744M
Average +0.78%+1.76%-21.32%+52.55% 5.83B
Weighted average by Cap. +0.02%-0.92%-35.40%+37.82%
Logo Tabula Rasa HealthCare, Inc.
Tabula Rasa HealthCare, Inc. is a healthcare technology company. The Company operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.
Employees
1,027
  1. Stock Market
  2. Stocks
  3. TRHC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!